Related Experiment Videos
A cellular mechanism governing the severity of Pelizaeus-Merzbacher disease
1Brookdale Center for Molecular Biology, Mount Sinai School of Medicine, New York, New York 10029-6574, USA.
Abstract:
Pelizaeus-Merzbacher disease (PMD) is a leukodystrophy linked to the proteolipid protein gene (PLP). We report a cellular basis for the distinction between two disease subtypes, classical and connatal, based on protein trafficking of the two PLP gene products (PLP and DM20). Classical PMD mutations correlate with accumulation of PLP in the ER of transfected COS-7 cells while the cognate DM20 traverses the secretory pathway to the cell surface. On the other hand, connatal PMD mutations lead to the accumulation of both mutant PLP and DM20 proteins in the ER of COS-7 cells with little of either isoform transported to the cell surface. Moreover, we show that transport-competent mutant DM20s facilitate trafficking of cognate PLPs and hence may influence disease severity.
Insights
Pelizaeus-Merzbacher disease subtypes differ in protein trafficking. Classical PMD shows PLP ER accumulation, while connatal PMD affects both PLP and DM20, impacting disease severity.
Area of Science:
- Neuroscience
- Cell Biology
- Genetics
Background:
- Pelizaeus-Merzbacher disease (PMD) is a rare, inherited neurological disorder affecting myelin.
- It is caused by mutations in the proteolipid protein gene (PLP), leading to dysmyelination.
- Two main subtypes, classical and connatal PMD, exhibit distinct clinical severities.
Purpose of the Study:
- To investigate the cellular mechanisms distinguishing classical and connatal PMD.
- To analyze the protein trafficking of PLP and DM20 isoforms in different PMD subtypes.
- To understand how mutations in the PLP gene affect protein transport and cellular localization.
Main Methods:
- Utilized COS-7 cells for transfection with wild-type and mutant PLP and DM20 constructs.
- Employed immunofluorescence microscopy to assess protein localization and trafficking.
- Compared the cellular accumulation and cell surface transport of PLP and DM20 isoforms in distinct PMD mutation models.
Main Results:
- Classical PMD mutations resulted in proteolipid protein (PLP) accumulation within the endoplasmic reticulum (ER), while DM20 reached the cell surface.
- Connatal PMD mutations caused both PLP and DM20 to accumulate in the ER, with minimal transport to the cell surface.
- Mutant DM20 proteins that were transport-competent could facilitate the trafficking of cognate PLP, suggesting a role in disease severity.
Conclusions:
- Protein trafficking defects of PLP and DM20 isoforms underlie the cellular differences between classical and connatal PMD.
- The differential ER retention or transport of PLP and DM20 provides a cellular basis for PMD subtype classification.
- Transport-competent mutant DM20 may modulate disease phenotype, offering insights into therapeutic strategies for Pelizaeus-Merzbacher disease.